Revisiting Dosing Regimen Using Pharmacokinetic/Pharmacodynamic Mathematical Modeling: Densification and Intensification of Combination Cancer Therapy.
about
Model driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasisModeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine.Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients.Mathematical modeling of efficacy and safety for anticancer drugs clinical development.Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach.Optimal dynamic regimens with artificial intelligence: The case of temozolomide.
P2860
Revisiting Dosing Regimen Using Pharmacokinetic/Pharmacodynamic Mathematical Modeling: Densification and Intensification of Combination Cancer Therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Revisiting Dosing Regimen Usin ...... of Combination Cancer Therapy.
@en
Revisiting Dosing Regimen Usin ...... of Combination Cancer Therapy.
@nl
type
label
Revisiting Dosing Regimen Usin ...... of Combination Cancer Therapy.
@en
Revisiting Dosing Regimen Usin ...... of Combination Cancer Therapy.
@nl
prefLabel
Revisiting Dosing Regimen Usin ...... of Combination Cancer Therapy.
@en
Revisiting Dosing Regimen Usin ...... of Combination Cancer Therapy.
@nl
P2093
P2860
P1476
Revisiting Dosing Regimen Usin ...... of Combination Cancer Therapy.
@en
P2093
Athanassios Iliadis
Christophe Meille
Dominique Barbolosi
Gilles Freyer
Joseph Ciccolini
P2860
P2888
P304
P356
10.1007/S40262-016-0374-7
P577
2016-03-05T00:00:00Z